COMPARATIVE STUDY OF INTRAVENOUS LABETALOL VERSUS ORAL NIFEDIPINE IN HYPERTENSIVE DISORDERS OF PREGNANCY IN A TERTIARY CARE HOSPITAL

Subhashree Priyadarshini, Pratima Mishra, Ruchita Richa

Abstract


Objective: To compare intravenous Labetalol and oral Nifedipine in terms of rapidity to control BP, no. of doses required,
maternal and fetal outcome in hypertensive disorders of pregnancy .
Methods:-All pregnant women with BP more than 150/100mmHg were randomized to receive IV labetalol ( in escalating
dose i,e 20,40,80,80,80 mg) and oral Nifedipine(10mg) until the target BP of 140/90 mmHg was achieved .
Results:- Mean time required in labetalol group was 43.5±15.7mins and Nifedipine was 44.7±15.7 mins with P >0.05.
There was significant fall in DBP with labetalol than nifedipine within 15mins. Maternal heart rate increased in nifedipine
group and decreased in labetalol group. No patients required cross over treatment.
Conclusion:- Both drugs are equally effective and safe in controlling BP in hypertensive disorders of pregnancy but
labetalol stood better to decrease DBP and no. of patients responding to 1st dose than Nife dipine


Keywords


Labetalol, Nifedipine, Hypertensive Disorders

Full Text:

PDF

References


1. Cunningham F, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY. Pregnancy hypertension. In: Dashe JS, Hoffman BL, editors. Williams Obstetrics. 23rd ed. NewYork: McGraw-Hill. 2010. p. 706-7.

Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: a systemic review. Lancet. 2006; 367:1066-1074.

Podymov T, August P. Update on the use of Antihypertensive drugs in pregnancy. Hypertension. 2008; 51:960-9.

AGOG Committee on Obstetric Practice. AGOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002; 99: 159-167.

National Institute of Health and Clinical excellence.2010.Hypertension in pregnancy: The management of hypertensive disorders during pregnancy.CG no 107. London: National Institute of Health and Clinical excellence.

Lakshmi B.S and Dasari P : Oral nifedipine versus intravenous labetalol in hypertensive

urgencies and emergencies of pregnancy: a randomized clinical trial. Obstetric

medicine, 02/06/13.

Alam A, Zakaria SMA. Oral nifedipine versus intravenous labetalol for acute blood pressure control in hypertensive emergencies of pregnancy: a randomized controlled trial. Int J Reprod Contracept Obstet Gynecol 2019; 8:1921-7.

Vermillion ST, Scardo JA, Newman RB, et al: A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy. Am J Obstet Gynecol 1999; 181:858–861.

Gavit Y, Sharma D, Dixit PV. A comparative study of oral nifedipine and intravenous labetalol in control of acute hypertension in severe pre-eclampsia and eclampsia. International Journal of Reproduction, Contraception, Obstet Gynecol. 2018; 7(2):719-24.

Raheem IA, Saaid R, Omar S Z. Oral nifedipine versus intravenous labetalol for acute

blood pressure control in hypertensive emergencies of pregnancy: a randomized trial:

BJOG 2011; DOI: 10.1111/j.1471-0528.2011.03151.x (E pub ahead of print)

. Kumari VR, Saraswathi K, Srilaxmi A. Oral nifedipine versus intravenous labetalol for control of blood pressure in severe preeclampsia. J Evolution Med Dent Sci. 2016; 5(20):994-7.

Chawla D "A comparative study of intravenous labetalol versus oral nifedipine in severe hypertension in pregnancy in a tertiary hospital ,New delhi" IOSR Journal of Dental and Medical Sciences (IOSR-JDMS), vol. 17, no. 3, 2018, pp 56-59.


Refbacks

  • There are currently no refbacks.